Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | Unknown | — |
The patient took dose of Vivotif which one box had temperature excursion for five hours, maximum temperature was 70 Fahrenheit; The patient took dose of Vivotif which one box had temperature excursion for five hours, maximum temperature was 70 Fahrenheit; Case reference number US-BN-2024-002120 is a spontaneous case initially received from pharmacist via agency (reference number USBAV24-1528) on 01-Jul-2024 and concerns a patient of unspecified age and gender. The patient's medical history and concomitant medication details were not provided. On an unspecified date, one box of Vivotif vaccine had temperature excursion for five hours, as reported, maximum temperature was 70 degrees Fahrenheit (explicitly coded 'Product storage error'). On 29-Jun-2024, the patient took first dose of Vivotif vaccine (batch number: unknown), at unknown dose, route or site of administration for unknown indication (explicitly coded as 'Product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240701-ca6629 to US-BAVARIAN NORDIC A/S-US-BN-2024-002120, in accordance with guidance on WWID formatting.; Reporter's Comments: A patient of unspecified age and gender took first dose of Vivotif vaccine, which had temperature excursion for five hours, as reported, maximum temperature was 70 degrees Fahrenheit (considered as product storage error) at unknown dose, route or site of administration for unknown indication which is considered as product administration error. Product administration error and product storage error are both considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. The patient's medical history and concomitant medications were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A patient of unspecified age and gender took first dose of Vivotif vaccine, which had temperature excursion for five hours, as reported, maximum temperature was 70 degrees Fahrenheit (considered as product storage error) at unknown dose, route or site of administration for unknown indication which is considered as product administration error. Product administration error and product storage error are both considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. The patient's medical history and concomitant medications were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious. USBAV24-1528:
Comments: None